Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open‐label, crossover, active‐comparator FIORE trial

AIM: To determine whether treatment with empagliflozin was able to affect the myocardial glucose metabolic rate, as assessed by cardiac dynamic (18)F‐fluorodeoxyglucose‐positron emission tomography ((18)F‐FDG‐PET) combined with euglycaemic‐hyperinsulinaemic clamp compared with glimepiride in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Succurro, Elena, Vizza, Patrizia, Papa, Annalisa, Miceli, Sofia, Cicone, Francesco, Fiorentino, Teresa Vanessa, Sciacqua, Angela, Andreozzi, Francesco, Veltri, Pierangelo, Cascini, Giuseppe Lucio, Sesti, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804559/
https://www.ncbi.nlm.nih.gov/pubmed/35837991
http://dx.doi.org/10.1111/dom.14816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804559/
https://www.ncbi.nlm.nih.gov/pubmed/35837991
http://dx.doi.org/10.1111/dom.14816

Ejemplares similares